➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Boehringer Ingelheim
Medtronic
AstraZeneca
Dow

Last Updated: January 15, 2021

DrugPatentWatch Database Preview

CALCIUM GLUCONATE IN SODIUM CHLORIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Calcium Gluconate In Sodium Chloride patents expire, and what generic alternatives are available?

Calcium Gluconate In Sodium Chloride is a drug marketed by Hq Spclt Pharma and is included in one NDA. There are two patents protecting this drug.

The generic ingredient in CALCIUM GLUCONATE IN SODIUM CHLORIDE is calcium gluconate. There are two hundred and eighty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the calcium gluconate profile page.

US ANDA Litigation and Generic Entry Outlook for Calcium Gluconate In Sodium Chloride

A generic version of CALCIUM GLUCONATE IN SODIUM CHLORIDE was approved as calcium gluconate by FRESENIUS KABI USA on June 15th, 2017.

  Start Trial

Summary for CALCIUM GLUCONATE IN SODIUM CHLORIDE
Drug patent expirations by year for CALCIUM GLUCONATE IN SODIUM CHLORIDE
Recent Clinical Trials for CALCIUM GLUCONATE IN SODIUM CHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Medical Universtity of LodzPhase 4
University of MalayaPhase 4
IRCCS Policlinico S. MatteoPhase 3

See all CALCIUM GLUCONATE IN SODIUM CHLORIDE clinical trials

Pharmacology for CALCIUM GLUCONATE IN SODIUM CHLORIDE

US Patents and Regulatory Information for CALCIUM GLUCONATE IN SODIUM CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-001 Oct 29, 2018 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-002 Oct 29, 2018 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-001 Oct 29, 2018 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-002 Oct 29, 2018 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Dow
Mallinckrodt
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.